Evoke Pharma Inc
F:EV0
Evoke Pharma Inc
F:EV0
Price:
0.2036
EUR
-9.99%
Market Cap:
€680.6k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Evoke Pharma Inc
F:EV0
|
US |
|
WM Technology Inc
OTC:MAPS
|
US |
|
Biotalys NV
F:86C
|
BE |
|
Judges Scientific PLC
F:IUF
|
UK |
|
M
|
Mixi Inc
F:MXN
|
JP |
|
Trip.com Group Ltd
F:CLVB
|
CN |
|
Robit Oyj
F:RO3
|
FI |
|
Metaplanet Inc
F:DN3
|
JP |
|
H
|
Haseko Corp
F:HS6
|
JP |
|
C
|
Crest Nicholson Holdings PLC
F:C38
|
UK |
|
A
|
Avance Gas Holding Ltd
F:A07
|
BM |
|
E
|
EVRAZ plc
F:EVZ
|
UK |
|
C
|
Canfor Pulp Products Inc
F:8CP
|
CA |
|
S
|
Super Micro Computer Inc
F:MS5
|
US |
|
B
|
Bebida Beverage Co
OTC:BBDA
|
US |
|
L
|
Linus Digital Finance AG
F:LDF
|
DE |
|
W
|
Woodside Petroleum Ltd
F:WOPA
|
AU |
|
WM Technology Inc
F:833
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EV0's stock price target?
Not Available
EV0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Evoke Pharma Inc?
Projected CAGR
52%
52%
The compound annual growth rate for Revenue over the next 3 years is 52%.
